Baxter International Inc. BAX
- Market cap
- $12.2B
- P/E
- 0.0×
Follow BAX
Baxter International Inc. (BAX) EV/Sales
As of 25 September 2026, Baxter International Inc. (BAX) trades at a EV/Sales of 1.7×. Over the past ten years it has ranged from 1.4× (March 2026) to 4.9× (February 2022); the current reading is higher than 6% of that period. That is below the Medical Instruments & Supplies industry median of 3.1× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.5× | (37.57%) |
| FY2024 | 2.5× | (15.77%) |
| FY2023 | 2.9× | (27.54%) |
| FY2022 | 4.0× | (15.08%) |
| FY2021 | 4.8× | 28.28% |
| FY2020 | 3.7× | (5.44%) |
| FY2019 | 3.9× | 18.35% |
| FY2018 | 3.3× | (4.11%) |
| FY2017 | 3.5× | 44.92% |
| FY2016 | 2.4× | 18.82% |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.6× | 12.38% |
| Mar 2026 | 1.4× | (7.64%) |
| Dec 2025 | 1.5× | (12.87%) |
| Sep 2025 | 1.8× | (17.59%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BAX Baxter International Inc. | 1.7× |
| BLCO Bausch + Lomb Corporation compare | 2.0× |
| AVTR Avantor, Inc. compare | 2.1× |
| ALGN Align Technology, Inc. compare | 2.3× |
| ATR AptarGroup, Inc. compare | 2.3× |
| SOLV Solventum Corporation compare | 2.4× |
| COO The Cooper Companies, Inc. compare | 3.1× |
| STVN Stevanato Group S.p.A. compare | 4.3× |
| RGEN Repligen Corporation compare | 13.4× |
| Medical Instruments & Supplies industry median | 3.1× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on BAX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement